Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-17

FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved Pfizer's supplemental application for CHANTIX (varenicline tartrate).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)

Snippet

SUPPL AP for CHANTIX (VARENICLINE TARTRATE)